Kang Jee Hyun, Lee Yoon Young, Yu Byung Yeon, Yang Beom-Seok, Cho Kyung-Hwan, Yoon Do Kyoung, Roh Yong Kyun
Department of Family Medicine, College of Medicine, Konyang University, Daejon 320-718, Korea.
Arch Pharm Res. 2005 Nov;28(11):1263-9. doi: 10.1007/BF02978210.
Recently, it was reported that reduction in serum adiponectin levels is correlated with the incidence of breast cancer. As an effort to explain this, we screened various human breast cancer cell lines to identify those in which proliferation is directly controlled by adiponectin. Among the five tested cell lines, proliferation of MDA-MB-231 cancer cell was significantly suppressed by adiponectin within the range of physiological concentration. Furthermore, prolonged adiponectin treatment caused cell growth arrest and even apoptosis of MDA-MB-231. This result is the first to show that adiponectin can directly control cancer cell growth and provides a rationale for the theory that reduction in plasma adiponectin levels could be a risk factor for breast cancer.
最近,有报道称血清脂联素水平降低与乳腺癌的发病率相关。为了解释这一现象,我们筛选了多种人类乳腺癌细胞系,以确定那些增殖直接受脂联素控制的细胞系。在五个受试细胞系中,生理浓度范围内的脂联素显著抑制了MDA-MB-231癌细胞的增殖。此外,长时间的脂联素处理导致MDA-MB-231细胞生长停滞甚至凋亡。这一结果首次表明脂联素可直接控制癌细胞生长,并为血浆脂联素水平降低可能是乳腺癌危险因素这一理论提供了依据。